We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CDMO market cap is 503.38M. The company's latest EPS is USD 0.0089 and P/E is 895.51.
| Quarter End | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 38.02M | 39.8M | 37.73M | 25.4M | 33.82M |
| Operating Income | 2.72M | 832k | -2.16M | -11.22M | -4M |
| Net Income | 461k | -309k | -2.09M | -9.51M | -6.05M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 53.6M | 59.7M | 95.87M | 119.6M | 149.27M |
| Operating Income | -5.62M | -10.94M | 12.24M | 15.42M | 3.6M |
| Net Income | -8.9M | -15.15M | 3.32M | 127.67M | 560k |
| Quarter End | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 450.43M | 451.05M | 442.34M | 454.64M | 455.23M |
| Total Liabilities | 265.04M | 261.58M | 251.74M | 270.97M | 275.06M |
| Total Equity | 185.4M | 189.47M | 190.6M | 183.68M | 180.17M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 78.4M | 107.62M | 265.51M | 429.84M | 451.05M |
| Total Liabilities | 25.33M | 65.72M | 187.77M | 255.32M | 261.58M |
| Total Equity | 53.07M | 41.9M | 77.74M | 174.53M | 189.47M |
| Quarter End | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.69M | -12.89M | -278k | 5.82M | 9.7M |
| Investing | -52.76M | -77.64M | -14.11M | -21.44M | -26.11M |
| Financing | 2.2M | 2.9M | 748k | 8.15M | 8.23M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.6M | 5.83M | 31.18M | 9.47M | -12.89M |
| Investing | 4.54M | -3.81M | -9.86M | -56.41M | -77.64M |
| Financing | -2.86M | 1.1M | 112.34M | 3.2M | 2.9M |
| Market Cap | 503.38M |
| Price to Earnings Ratio | 895.51 |
| Price to Sales Ratio | 3.38 |
| Price to Cash Ratio | 13.08 |
| Price to Book Ratio | 2.66 |
| Dividend Yield | - |
| Shares Outstanding | 63.24M |
| Average Volume (1 week) | 678.89k |
| Average Volume (1 Month) | 875.06k |
| 52 Week Change | -51.64% |
| 52 Week High | 17.39 |
| 52 Week Low | 4.0705 |
| Spread (Intraday) | 2.96 (35.58%) |
| Company Name | Avid Bioservices Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.peregrineinc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
